Measurements that look at the interplay between the pulmonary arteries and the heart may help predict the likelihood of survival among people with all forms of pulmonary hypertension (PH), according to a study. These measurements were able to predict mortality risk even in mild PH, whereas conventional disease severity…
Discussion
When it comes to scheduling appointments, I say the earlier the better. I love first-thing-in-the-morning physical therapy sessions. The commute is quieter, as my neighborhood and city are still waking up, and the late-summer heat hasn’t yet turned the concrete into hot stones. There’s a sense of accomplishment in finishing…
Discussion
Mosliciguat, an inhaled treatment being developed by Pulmovant, was well tolerated and more effective than a placebo at improving blood flow through the lungs of adults with pulmonary hypertension associated with interstitial lung disease (PH-ILD), supporting its move into Phase 3 clinical testing, which is already underway. That’s…
Discussion
The PAH Initiative will once again host a live broadcast event — this time focusing on how oxygen therapy can become part of the care plan for people living with pulmonary arterial hypertension (PAH) — and registration for the free hour-long program is now open. The event, called…
Discussion
Discussion
Discussion
Discussion
Discussion
Discussion
Get regular updates to your inbox.
